Polysaccharides-based polyelectrolyte nanoparticles as protein drugs delivery system
Source abstract
Abstract
Polysaccharides-based nanoparticles were prepared by synthesized quaternized chitosan and dextran sulfate through simple ionic-gelation self-assembled method. Introduction of quaternized groups was intended to increase water solubility of chitosan and make the nanoparticles have broader pH sensitive range which can remain more stable in physiological pH and decrease the loss of protein drugs caused by the gastric cavity. The load of BSA was affected by molecular parameter, i.e., degree of substitution, and average molecular weight of quaternized chitosan, as well as concentration of BSA. Fast release occurred in phosphate buffer solution (pH 7.4) while the release was slow in hydrochloric acid (pH 1.4). The drug release mechanism is Fickian diffusion through release kinetics analysis. Cell uptake demonstrated nanoparicles can internalize into Caco-2 cells, which suggested that nanoparticles had good biocompatibility. No significant conformation change was noted for the released BSA in comparison with native BSA using circular dichroism spectroscopy. This kind of novel composite nanoparticles may be a promising delivery system for oral protein and peptide drugs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Hydrogels: synthesis, properties, applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Aboubakar M, Couvreur P, Pinto-Alphandary H, Gouritin B, Lacour B, Farinotti R et al (2000) Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation. Drug Dev Res 49:109–11710.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-# ↗
2. Agnihotri SA, Mallikarjuna NN, Aminabhvi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5–2810.1016/j.jconrel.2004.08.010 ↗
3. Alonso-Sande M, Cuna M, Remunan-lopez C, Teijeiro-Osorio D, Alonso-Lebrero JL, Alonso MJ (2006) Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins. Macromolecules 39:4152–415810.1021/ma060230j ↗
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–25410.1016/0003-2697(76)90527-3 ↗
5. Carino GP, Mathiowitz E (1999) Oral insulin delivery. Adv Drug Deliv Rev 35:249–25710.1016/S0169-409X(98)00075-1 ↗
6. Dai ZZ, Yin JB, Yan SF, Cao T, Ma J, Chen XS (2007) Polyelectrolyte complexes based on chitosan and poly(l-glutamic acid). Polym Int 27:1122–1127
7. De Geest BG, Vandenbroucke RE, Guenther AM, Sukhorukov GB, Hennink WE, Sanders NN et al (2006) Intracellularly degradable polyelectrolyte microcapsules. Adv Mater 18:1005–100910.1002/adma.200502128 ↗
8. George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–1410.1016/j.jconrel.2006.04.017 ↗
9. Greenfield N, Fasman GD (1969) Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108–411610.1021/bi00838a031 ↗
10. Hu Y, Jiang XQ, Ding Y, Ge HX, Yuan YY, Yang CZ (2002) Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials 23:3193–320110.1016/S0142-9612(02)00071-6 ↗
11. Jia ZJ, Shen DF, Xu WL (2001) Synthesis and antibacterial activities of quaternary ammonium salt of chitosan. Carbohydr Res 333:1–610.1016/S0008-6215(01)00112-4 ↗
12. Kotzé AF, Thanou MM, Lueßen HL, Boer BG, Verhoef JC, Junginger HE (1999) Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (caco-2). Eur J Pharm Biopharm 47:125–13210.1016/S0939-6411(98)00074-5 ↗
13. Li HB, Du YM, Zhan HY (2004) Effect of molecular weight and degree of substitution of quaternary chitosan on its adsorption and flocculation properties for potential retention-aids in alkaline papermaking. Colloid Surf A Physicochem Eng Asp 242:1–810.1016/j.colsurfa.2004.04.051 ↗
14. Li T, Shi XW, Du YM, Tang YF (2007) Quaternized chitosan/alginate nanoparticles for protein delivery. J Biomed Mater Res 83:383–39010.1002/jbm.a.31322 ↗
15. Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW (2005) Preparation of nanoparticles composed of chitosan/poly-γ-glutamic acid and evaluation of their permeability through caco-2 cells. Biomacromolecules 6:1104–111210.1021/bm049312a ↗
16. Mi FL, Wu YY, Lin YH, Sonaje K, Ho YC, Chen CT, Juang JH, Sung HW (2008) Oral delivery of peptide drugs using nanoparticles self-assembled by poly(γ-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug Chem 19:1248–125510.1021/bc800076n ↗
17. Nam C-W, Kim Y-H, Ko S-W (1999) Midification of polyacrylonitrile fiber by blending with N-(2-Hydroxy) propyl-3-trimethyl-ammonium chitosan chloride. J Appl Polym Sci 74:2258–226510.1002/(SICI)1097-4628(19991128)74:9<2258::AID-APP15>3.0.CO;2-9 ↗
18. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G et al (2002) Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–14710.1016/S0378-5173(02)00486-6 ↗
19. Peng ZG, Hidajat K, Uddin MS (2004) Adsorption and desorption of lysozyme on nano-sized magnetic particles and its conformational changes. Colloids Surf B Biointerface 35:169–17410.1016/j.colsurfb.2004.03.010 ↗
20. Peppas NA (1985) A model of dissolution-controlled solute release from porous drug-delivery polymeric systems. Pharm Acta Helv 60:110–111
21. Sarmento B, Ribeiro AO, Veiga F, Ferreira D (2006) Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerface 53:193–20210.1016/j.colsurfb.2006.09.012 ↗
22. Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007) Oral bioavailability of insulin contained in polysarccharide nanoparticles. Biomacromolecules 8:3054–306010.1021/bm0703923 ↗
23. Schatz C, Domard A, Viton C, Pichot C, Delair T (2004) Versatile and efficient formation of colloids of biopolymer-based polyelectrolyte complexes. Biomacromolecules 5:1882–189210.1021/bm049786+ ↗
24. Sukhorukov GB, Rogach AL, Zebli B, Liedl T, Skirtach AG, Kchler K et al (2005) Nanoengineered polymer capsules: tools for detection, controlled delivery, and site-specific manipulation. Small 1:194–20010.1002/smll.200400075 ↗
25. Wang SB, Chen AZ, Weng LJ, Chen MY, Xie XL (2004) Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-l-arginine/chitosan ternary complex microcapsules. Macromol Biosci 4:27–3010.1002/mabi.200300043 ↗
26. Xu YM, Du YM, Huang RH, Gao LP (2003) Preparation and modification of N-(2-hydroxyl)propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 24:5015–502210.1016/S0142-9612(03)00408-3 ↗
27. Yu JH, Du YM, Zheng H (1999) Blend films of chitosan–gelation. J Wuhan Univ (Nat Sci Ed) 45:440–444